NOS2 and cancer: In previous work, we established that iNOS-derived NO played a dominant role in the accelerated growth and migration of surviving ALA/light-challenged cancer cells by showing that these responses were strongly attenuated by iNOS inhibitor 1400 W or NO scavenger cPTIO.